{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:12:35Z","timestamp":1790503955823,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,28]],"date-time":"2018-04-28T00:00:00Z","timestamp":1524873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40249-018-0421-8","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T23:09:07Z","timestamp":1524179347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing \u201cOne Health\u201d community surveillance and emergency response practice"],"prefix":"10.1186","volume":"7","author":[{"given":"Ernest","family":"Tambo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwasegun T.","family":"Adetunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwasogo A.","family":"Olalubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,28]]},"reference":[{"key":"421_CR1","unstructured":"WHO, NCDC. Technical Guidelines for Integrated Disease Surveillance and Response in Nigeria. Abuja; 2013."},{"key":"421_CR2","unstructured":"WHO, CDC. Technical Guidelines for Integrated Disease Surveillance and Response in the African Region. Brazzaville and Atlanta; 2010."},{"key":"421_CR3","doi-asserted-by":"publisher","unstructured":"Mofolorunsho KC. Outbreak of lassa fever in Nigeria: Measures for prevention and control. Pan Afr Med J. 2016;23(210) \n                    https:\/\/doi.org\/10.11604\/pamj.2016.23.210\n                    \n                  .","DOI":"10.11604\/pamj.2016.23.210"},{"key":"421_CR4","unstructured":"Nigeria Centre for Disease Control. Experts Meet to Discuss Lassa Fever Control. Wkly Epidemiol Rep. 2017:1\u201312. [cited 2017 Sep 5] Available from: \n                    http:\/\/www.ncdc.gov.ng\/reports\/weekly"},{"key":"421_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2049-9957-3-29","volume":"3","author":"E Tambo","year":"2014","unstructured":"Tambo E, Ugwu EC, Ngogang JY. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. Infect Dis Poverty. 2014;3:29. \n                    https:\/\/doi.org\/10.1186\/2049-9957-3-29\n                    \n                  .","journal-title":"Infect Dis Poverty."},{"key":"421_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/trstmh\/trv047","volume":"109","author":"AQN Mylne","year":"2015","unstructured":"Mylne AQN, Pigott DM, Longbottom J, Shearer F, Duda KA, Messina JP, et al. Mapping the zoonotic niche of Lassa fever in Africa. Trans R Soc Trop Med Hyg. 2015;109:483\u201392.","journal-title":"Trans R Soc Trop Med Hyg."},{"issue":"3","key":"421_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4314\/ajcem.v10i3.43407","volume":"10","author":"GM Adewuyi","year":"2009","unstructured":"Adewuyi GM, Fowotade A, Adewuyi BT. LASSA FEVER\u00a0: ANOTHER INFECTIOUS MENACE. African J Clin Exp Microbiol. 2009;10(3):144\u201355.","journal-title":"African J Clin Exp Microbiol."},{"issue":"1","key":"421_CR8","first-page":"16","volume":"1","author":"D Ogoina","year":"2015","unstructured":"Ogoina D. Lassa fever\u00a0:A clinical and epidemiological review. Niger Delta J Med Med Res. 2015;1(1):16\u201322.","journal-title":"Niger Delta J Med Med Res."},{"key":"421_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/374853","volume":"36","author":"WH Haas","year":"2003","unstructured":"Haas WH, Breuer T, Pfaff G, Schmitz H, Kohler P, Asper M, et al. Imported Lassa Fever in Germany: Surveillance and management of contact persons. Clin Infect Dis. 2003;36:1254\u20137.","journal-title":"Clin Infect Dis."},{"issue":"12","key":"421_CR10","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3201\/eid1212.060812","volume":"12","author":"E Lecompte","year":"2006","unstructured":"Lecompte E, Fichet-calvet E, Soropogui B, Aniskin V, Allali B, Kan SK, et al. Mastomys natalensis and Lassa Fever, West Africa. Emerg Infect Dis. 2006;12(12):1971\u20134.","journal-title":"Emerg Infect Dis."},{"issue":"2","key":"421_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/2276-7096.162258","volume":"17","author":"EA Tobin","year":"2015","unstructured":"Tobin EA, Asogun D, Akpede N, Adomeh D, Odia I, Gunther S. Lassa fever in Nigeria: Insights into seroprevalence and risk factors in rural Edo State\u00a0: A pilot study. J Med Trop. 2015;17(2):51\u20135.","journal-title":"J Med Trop."},{"key":"421_CR12","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","volume":"327","author":"JK Richmond","year":"2003","unstructured":"Richmond JK, Baglole DJ. Lassa fever: Epidemiology, clinical features and social consequences. BMJ Clin Rev. 2003;327:1271\u20135.","journal-title":"BMJ Clin Rev."},{"issue":"4","key":"421_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/IJTDH\/2017\/32823","volume":"24","author":"JO Olayiwola","year":"2017","unstructured":"Olayiwola JO, Bakarey AS. Epidemiological trends of Lassa fever outbreaks and insights for future control in Nigeria. Int J Trop Dis Heal. 2017;24(4):1\u201314.","journal-title":"Int J Trop Dis Heal."},{"issue":"7","key":"421_CR14","first-page":"29","volume":"4","author":"V Koga","year":"2016","unstructured":"Koga V, Nwadiaro EC. Lassa Fever: Focus on Medical\/Academic Research and Popular Press Depiction. Glob J Arts, Humanit Soc Sci. 2016;4(7):29\u201336.","journal-title":"Glob J Arts, Humanit Soc Sci."},{"issue":"4","key":"421_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3201\/eid2104.141469","volume":"21","author":"TA Leski","year":"2015","unstructured":"Leski TA, Stockelman MG, Moses LM, Park M, Stenger DA, Ansumana R, et al. Sequence variability and geographic distribution of Lassa virus, Sierra Leone. Emerg Infect Dis. 2015;21(4):609\u201317.","journal-title":"Emerg Infect Dis."},{"key":"421_CR16","unstructured":"World Health Organization. WHO Target Product Profile for Lassa virus Vaccine, June 2017. \n                    http:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/LassaVirusVaccineTPP.PDF\n                    \n                  . Accessed 12 Dec 2017."},{"key":"421_CR17","unstructured":"NCDC. Viral Haemorrhagic Fevers preparedness and response plan. Abuja; 2017."},{"key":"421_CR18","unstructured":"Roth S, Landry M, Ebener S, Marcelo A, Kijsanayotin B, Parry J. The Geography of Universal Health Coverage. Manila; 2016. Report No.: 55."},{"key":"421_CR19","unstructured":"O\u2019Connell T, Sharkey A. Reaching Universal Health Coverage through District Health System Strengthening: Using a modified Tanahashi model sub-nationally to attain equitable and effective coverage, Maternal, Newborn and Child Health Working Paper, UNICEF Health Section. New York; 2013."},{"key":"421_CR20","unstructured":"WHO. Everybody\u2019s Business: Strengthening Health Systems to Improve Health Outcomes. Geneva; 2007."},{"key":"421_CR21","unstructured":"WHO. The World Health Report 2000 Health systems: improving performance. Geneva; 2000."},{"key":"421_CR22","doi-asserted-by":"publisher","unstructured":"Giles EL, Adams JM. Capturing public opinion on public health topics: A comparison of experiences from a systematic review, focus group study and analysis of online, user-generated content. Front Public Heal. 2015;3 \n                    https:\/\/doi.org\/10.3389\/fpubh.2015.00200\n                    \n                  .","DOI":"10.3389\/fpubh.2015.00200"},{"issue":"1","key":"421_CR23","first-page":"1","volume":"27","author":"C Hooker","year":"2017","unstructured":"Hooker C, Capon A, Leask J. Communicating about risk: strategies for situations where public concern is high, but the risk is low. Public Heal Res Pract. 2017;27(1):1\u20135.","journal-title":"Public Heal Res Pract."},{"key":"421_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/1471-2458-10-535","volume":"10","author":"J Leask","year":"2010","unstructured":"Leask J, Hooker C, King C. Media coverage of health issues and how to work more effectively with journalists: A qualitative study. BMC Public Health. 2010;10:535\u201342.","journal-title":"BMC Public Health."},{"issue":"4","key":"421_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3201\/eid0604.000403","volume":"6","author":"V Freimuth","year":"2000","unstructured":"Freimuth V, Linnan HW, Potter P. Communicating the threat of emerging infections to the public. Emerg Infect Dis. 2000;6(4):337\u201347.","journal-title":"Emerg Infect Dis."},{"key":"421_CR26","unstructured":"WHO. Infection prevention and control: Guidance for care of patients with suspected or confirmed Filovirus Haemorrhagic Fever in health- care settings, with focus on Ebola. Geneva; 2014."},{"key":"421_CR27","unstructured":"NCDC. Standard operating procedures for Lassas fever case management. Abuja; 2017."},{"key":"421_CR28","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","volume":"311","author":"SP Fisher-Hoch","year":"1995","unstructured":"Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L, et al. Review ofcases of nosocomial Lassa fever in Nigeria: The high price of poor medical practice. BMJ. 1995;311:857\u20139.","journal-title":"BMJ."},{"key":"421_CR29","unstructured":"CDC, WHO. Infection Control for Viral Haemorrhagic Fevers in the African Health Care Setting. Atlanta; 1998."},{"key":"421_CR30","unstructured":"Nigeria Centre for Disease Control (NCDC). Situation report week 15, 2018 Lassa Fever outbreak in Nigeria. 2018. \n                    http:\/\/www.ncdc.gov.ng\/diseases\/sitreps\/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria\n                    \n                  . Accessed 14 Apr 2018."},{"issue":"12","key":"421_CR31","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0027-9684(15)30780-X","volume":"102","author":"V Idemyor","year":"2010","unstructured":"Idemyor V. Lassa Virus Infection in Nigeria: Clinical Perspective Overview. J Natl Med Assoc. Elsevier Masson SAS. 2010;102(12):1243\u20136.","journal-title":"J Natl Med Assoc"},{"issue":"12","key":"421_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/esm.09.12.00490-en","volume":"9","author":"P Bossi","year":"2004","unstructured":"Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, et al. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses. Eurosurveillance. 2004;9(12):1\u20138.","journal-title":"Eurosurveillance."},{"issue":"12","key":"421_CR33","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1086\/657315","volume":"51","author":"DG Bausch","year":"2015","unstructured":"Bausch DG, Hadi CM, Khan SH, Lertora JJL. Review of the literature and proposed guidelines for the use of oral ribavirin as Postexposure Prophylaxis for Lassa Fever. Clin Infect Dis. 2015;51(12):1435\u201341.","journal-title":"Clin Infect Dis."},{"issue":"2","key":"421_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4269\/ajtmh.1988.38.407","volume":"38","author":"O Tomori","year":"1988","unstructured":"Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB. Viral Hemorrhagic Fever Antibodies in Nigerian Populations. Am J Trop Med Hyg. 1988;38(2):407\u201310.","journal-title":"Am J Trop Med Hyg."},{"issue":"1","key":"421_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40249-017-0278-2","volume":"6","author":"E Tambo","year":"2017","unstructured":"Tambo E, Chengho CF, Ugwu CE, Wurie I, Jonhson JK, Ngogang JY. Rebuilding transformation strategies in post-Ebola epidemics in Africa. Infect Dis Poverty. 2017;6(1):71.","journal-title":"Infect Dis Poverty"},{"issue":"7","key":"421_CR36","doi-asserted-by":"publisher","first-page":"e0005711","DOI":"10.1371\/journal.pntd.0005711","volume":"11","author":"OC Akhuemokhan","year":"2017","unstructured":"Akhuemokhan OC, Ewah-Odiase R, Akpede N, Ehimuan J, Adomeh DI, Odia I, Olomu SC, Pahlmann M, Becker-Ziaja B, Happi CT, Asogun DA, Okogbenin SA, Okokhere PO, Dawodu OS, Omoike IU, Sabeti PC, G\u00fcnther S, Akpede GO. Prevalence of Lassa Virus Disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area. PLoS Negl Trop Dis. 2017;11(7):e0005711.","journal-title":"PLoS Negl Trop Dis."},{"key":"421_CR37","doi-asserted-by":"crossref","unstructured":"Hallam HJ, Hallam S, Rodriguez SE, Barrett ADT, Beasley DWC, Chua A, Ksiazek TG, Milligan GN, Sathiyamoorthy V, Reece LM. Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development. NPJ Vaccines. 2018;3:\u201311.","DOI":"10.1038\/s41541-018-0049-5"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-018-0421-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40249-018-0421-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-018-0421-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T19:05:14Z","timestamp":1556391914000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-018-0421-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,28]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["421"],"URL":"https:\/\/doi.org\/10.1186\/s40249-018-0421-8","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,28]]},"assertion":[{"value":"13 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors consent for open access publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}